U

University of Debrecen | Clinical Center - Dermatology Department

Research site
(Unclaimed)
Location
98 Nagyerdei Boulevard, Debrecen, Debrecen, Hungary
Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

7 of 61
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
A Phase III, Safety, Tolerability and Efficacy of Combination Treatment of BL-8040 and G-GSF as Compared to Placebo and G-CSF for the Mobilization of Hematopoietic Stem Cells for Autologous TransplantatIon in Subjects With MM (GENESIS)

A total of 122 subjects were randomized into the study and investigated in the double-blind placebo-controlled setting to assess the efficacy and saf...

Active, not recruiting
Multiple Myeloma
Drug: BL-8040 1.25 mg/kg + G-CSF
Drug: Placebo +G-CSF

This study is comparing 200 milligrams (mg) of filgotinib a day with a placebo to see if filgotinib helps to treat Axial Spondyloarthritis (axSpA) an...

Enrolling
Axial Spondyloarthritis
Drug: Placebo
Drug: Filgotinib

The purpose of this study is to assess the objective response rate of parsaclisib treatment in participants with relapsed or refractory follicular ly...

Active, not recruiting
Lymphoma
Drug: Parsaclisib

This study is researching an experimental drug called REGN3767, also known as fianlimab (R3767), when combined with another medication called REGN281...

Enrolling
Melanoma
Drug: Cemiplimab
Drug: Placebo

The study is designed to assess the efficacy, safety, tolerability, and transformation within the human body of INV-202 investigational drug in the t...

Enrolling
Diabetic Kidney Disease
Drug: Placebo
Drug: INV-202

A multicenter Phase 2 study to evaluate the pharmacokinetics, efficacy, and safety of intravenous BV100 combined with Polymyxin B in adult patients w...

Enrolling
Ventilator Associated Pneumonia
Drug: BAT
Drug: BV100 plus Polymyxin B

The purpose of this study is to assess the efficacy and safety of of tafasitamab plus lenalidomide in adults with diffuse large B-cell lymphoma (DLBC...

Enrolling
Large B-Cell Lymphoma
Diffuse Large B-Cell Lymphoma
Drug: Tafasitamab
Drug: Lenalidomide

Trial conditions

Dermatomyositis (3 trials)
Hypertension (3 trials)
Lymphoma (3 trials)
Polycythemia (3 trials)
Polycythemia Vera (3 trials)
Atherosclerosis (2 trials)
B-Cell Lymphoma (2 trials)
Brain Cancer (2 trials)
Breast Cancer (2 trials)
Cerebral Hemorrhage (2 trials)

And 76 more

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems